V Catalano - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

V Catalano

Showing results (81-90 of 85) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 85 results.

The New England Journal of Medicine|March 2, 2012

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosisSrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2012

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases studyD Santini, M Tampellini, B Vincenzi, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2019

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA StudyEmmanuel Bachy, John F Seymour, Pierre Feugier, et al.

Haematologica|August 6, 2013

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studiesRuben A Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, et al.

Blood|November 19, 2017

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myelomaThierry Facon, Meletios A Dimopoulos, Angela Dispenzieri, et al.

Pageof 9

Search research articles

Showing results (81-90 of 85) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 85 results.

The New England Journal of Medicine|March 2, 2012

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosisSrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2012

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases studyD Santini, M Tampellini, B Vincenzi, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2019

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA StudyEmmanuel Bachy, John F Seymour, Pierre Feugier, et al.

Haematologica|August 6, 2013

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studiesRuben A Mesa, Jean-Jacques Kiladjian, Srdan Verstovsek, et al.

Blood|November 19, 2017

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myelomaThierry Facon, Meletios A Dimopoulos, Angela Dispenzieri, et al.

Pageof 9